OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
OraSure Technologies, Inc. (NASDAQ: OSUR) has announced its upcoming earnings conference call for the second quarter of 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OraSure Technologies, Inc. (NASDAQ: OSUR) has announced its upcoming earnings conference call for the second quarter of 2024. The call is scheduled for August 6, 2024, at 5 p.m. ET. Investors and interested parties can access the webcast through OraSure's investor relations website. The company will discuss its Q2 2024 financial results and provide updates on certain business developments during the call.
To participate and ask questions during the conference, attendees must pre-register using the provided link. The webcast will be archived on OraSure's website for approximately 90 days after the call. This announcement allows investors to prepare for the upcoming financial disclosure and gain insights into the company's recent performance and future outlook.
Details
News Market Reaction – OSUR
The recorded move for OSUR in the trading session of this news was -0.69%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business developments for 5 p.m. ET on August 6, 2024.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately 90 days.
For participants interested in asking questions during the conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.
https://register.vevent.com/register/BIe57bba25d853415d8352e2aa4f12a85a
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiary, DNA Genotek Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com
| Investor Contact: Jason Plagman VP, Investor Relations investorinfo@orasure.com | Media Contact: Amy Koch Director, Corporate Communications media@orasure.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.